A vaccine antigen created by AI has now successful moved on to the human testing stage following a small Phase 1 trial.
Analysis - The ongoing Ebola virus outbreak in the Democratic Republic of Congo (DRC) and Uganda has now killed 61 people, with 359 confirmed cases. The Bundibugyo strain of the virus has a fatality ...
A coronavirus vaccine built to stay useful even as viruses change has cleared its first test in people, offering an early ...
For most of modern vaccine history, scientists have had to wait for that door to open until they could design a vaccine ...
SHELTON, CT / ACCESS Newswire / June 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides ...
The COVID-19 pandemic showed how quickly a virus can spread across the world and disrupt daily life. Millions of people ...
The virologist was stopped at the Detroit airport after working in Congo during an mpox epidemic. His lawyer said the ...
A Cambridge laboratory has run the first human trial of a vaccine whose active ingredient was designed entirely by artificial ...
Doctors Without Border (MSF) personnel at the Elikya clinic Ebola treatment center is sprayed with disinfectants upon leaving ...
Scientists tested a new kind of vaccine, one whose key ingredient was designed by a computer to fight a whole family of ...
After COVID cost South Africa deeply in lives and livelihoods, the idea of getting ahead of the curve rather than chasing ...